Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles

PloS One
Rhonda C KinesBarney S Graham

Abstract

Human papilloma virus-like particles (HPV VLP) serve as the basis of the current licensed vaccines for HPV. We have previously shown that encapsidation of DNA expressing the model antigen M/M2 from respiratory syncytial virus (RSV) in HPV pseudovirions (PsV) is immunogenic when delivered intravaginally. Because the HPV capsids confer tropism for basal epithelium, they represent attractive carriers for vaccination targeted to the skin using microneedles. In this study we asked: 1) whether HPV16 VLP administered by microneedles could induce protective immune responses to HPV16 and 2) whether HPV16 PsV-encapsidated plasmids delivered by microneedles could elicit immune responses to both HPV and the antigen delivered by the transgene. Mice immunized with HPV16 VLP coated microneedles generated robust neutralizing antibody responses and were protected from HPV16 challenge. Microneedle arrays coated with HPV16-M/M2 or HPV16-F protein (genes of RSV) were then tested and dose-dependent HPV and F-specific antibody responses were detected post-immunization, and M/M2-specific T-cell responses were detected post RSV challenge, respectively. HPV16 PsV-F immunized mice were fully protected from challenge with HPV16 PsV and had reduced RSV vi...Continue Reading

References

Oct 1, 1988·Journal of Medical Virology·B S GrahamD T Karzon
Nov 5, 2004·The New England Journal of Medicine·Richard T KenneyGregory M Glenn
Dec 16, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Harvinder S Gill, Mark R Prausnitz
Feb 20, 2007·Current Gene Therapy·Cyril FavardMarie-Pierre Rols
Feb 7, 2009·The New England Journal of Medicine·Caroline Breese HallPeter Szilagyi
Sep 19, 2009·Nature Reviews. Immunology·Frank O NestleBrian J Nickoloff
Jun 17, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lauren A HiraoDavid B Weiner
Jul 20, 2010·Nature Medicine·Sean P SullivanMark R Prausnitz
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Aug 6, 2011·The Pediatric Infectious Disease Journal·Lauren J StockmanGayle Fischer-Langley
Oct 7, 2011·The Lancet Infectious Diseases·Julie E LedgerwoodUNKNOWN VRC 306 Study Team
Dec 17, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shari N GordonGenoveffa Franchini
Feb 23, 2012·Scientific Reports·Emilio González-GonzálezRoger L Kaspar
Apr 18, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jae-Min SongSang-Moo Kang
Apr 21, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marc PeartonJames C Birchall
May 12, 2012·The Lancet Oncology·Catherine de MartelMartyn Plummer
May 12, 2012·Advanced Drug Delivery Reviews·Yeu-Chun KimMark R Prausnitz
Oct 10, 2012·Vaccine·Chris EdensMark R Prausnitz
Nov 13, 2012·The Journal of Clinical Investigation·Nicolas ÇuburuJohn T Schiller
Feb 7, 2013·Proceedings of the National Academy of Sciences of the United States of America·Veronique BachyLinda S Klavinskis

❮ Previous
Next ❯

Citations

Nov 13, 2015·Expert Opinion on Drug Delivery·N Sanoj RejinoldYeu-Chun Kim
Oct 19, 2016·Human Vaccines & Immunotherapeutics·Sarah MarshallAnne C Moore
Jul 1, 2015·Drug Delivery and Translational Research·Joanne McCaffreyHelen O McCarthy
Sep 27, 2016·Human Vaccines & Immunotherapeutics·Chao WangZhen Gu
Jun 19, 2018·PloS One·Lea BayerThomas Grunwald
Sep 6, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Edward P Rybicki
Jun 25, 2020·Pharmaceutics·Antonio José GuillotAna Melero
Jun 30, 2019·Advanced Materials·C Wyatt ShieldsSamir Mitragotri
Jun 30, 2019·Bioengineering & Translational Medicine·Michelle E TurveyPaula T Hammond
Apr 7, 2016·Experimental Biology and Medicine·Eric FarrisAngela K Pannier
Jun 9, 2019·The Journal of Pharmacology and Experimental Therapeutics·Rohan S J Ingrole, Harvinder Singh Gill
Dec 3, 2020·Pathogens·Inge PietersenInga Hitzeroth
Feb 5, 2021·Advanced Drug Delivery Reviews·Emrullah KorkmazLouis D Falo
Jun 22, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·E Stein EsserIoanna Skountzou
May 24, 2021·Drug Delivery and Translational Research·Fang-Ying WangChao-Min Cheng
Aug 11, 2021·Advanced Drug Delivery Reviews·Tao ShengZhen Gu

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
bronchoalveolar lavage
ELISA
flow cytometry
scraping

Software Mentioned

ImageJ
Excel
Living Image
GraphPad Prism
SigmaStat
GraphPad
Flow Jo

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.